CytoMed Therapeutics Limited (GDTC)
Total Valuation
GDTC has a market cap or net worth of $25.83 million. The enterprise value is $18.44 million.
Market Cap | 25.83M |
Enterprise Value | 18.44M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
GDTC has 11.53 million shares outstanding. The number of shares has increased by 95.49% in one year.
Shares Outstanding | 11.53M |
Shares Change (YoY) | +95.49% |
Shares Change (QoQ) | +45.66% |
Owned by Insiders (%) | 70.80% |
Owned by Institutions (%) | 0.08% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 45.02 |
Forward PS | 48.69 |
PB Ratio | 2.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 32.15 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.42, with a Debt / Equity ratio of 0.04.
Current Ratio | 36.42 |
Quick Ratio | 36.42 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -40.32 |
Financial Efficiency
Return on equity (ROE) is -58.30% and return on invested capital (ROIC) is -18.42%.
Return on Equity (ROE) | -58.30% |
Return on Assets (ROA) | -45.00% |
Return on Capital (ROIC) | -18.42% |
Revenue Per Employee | $21,244 |
Profits Per Employee | -$117,873 |
Employee Count | 27 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, GDTC has paid $1,216 in taxes.
Income Tax | 1,216 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 2.64 |
200-Day Moving Average | 3.46 |
Relative Strength Index (RSI) | 43.78 |
Average Volume (30 Days) | 38,395 |
Short Selling Information
The latest short interest is 19,259, so 0.17% of the outstanding shares have been sold short.
Short Interest | 19,259 |
Short Previous Month | 19,285 |
Short % of Shares Out | 0.17% |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.04 |
Income Statement
In the last 12 months, GDTC had revenue of $573,593 and -$3.18 million in losses. Loss per share was -$0.36.
Revenue | 573,593 |
Gross Profit | n/a |
Operating Income | -1.86M |
Pretax Income | -3.18M |
Net Income | -3.18M |
EBITDA | -2.80M |
EBIT | -3.10M |
Loss Per Share | -$0.36 |
Balance Sheet
The company has $7.74 million in cash and $349,946 in debt, giving a net cash position of $7.39 million or $0.64 per share.
Cash & Cash Equivalents | 7.74M |
Total Debt | 349,946 |
Net Cash | 7.39M |
Net Cash Per Share | $0.64 |
Equity / Book Value | 9.76M |
Book Value Per Share | 0.85 |
Working Capital | 8.27M |
Cash Flow
In the last 12 months, operating cash flow was -$2.21 million and capital expenditures -$50,667, giving a free cash flow of -$2.26 million.
Operating Cash Flow | -2.21M |
Capital Expenditures | -50,667 |
Free Cash Flow | -2.26M |
FCF Per Share | -$0.20 |
Margins
Gross Margin | n/a |
Operating Margin | -324.61% |
Pretax Margin | -554.64% |
Profit Margin | -554.85% |
EBITDA Margin | -488.88% |
EBIT Margin | -541.21% |
FCF Margin | -393.97% |
Dividends & Yields
GDTC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -95.49% |
Shareholder Yield | -95.49% |
Earnings Yield | -12.32% |
FCF Yield | -8.75% |
Analyst Forecast
The average price target for GDTC is $5.00, which is 130.42% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 130.42% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GDTC has an Altman Z-Score of 27 and a Piotroski F-Score of 3.
Altman Z-Score | 27 |
Piotroski F-Score | 3 |